A Study of LY3522348 in Healthy Participants

NCT04559568 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3522348
DRUG: Placebo
DRUG: Midazolam

Sponsor

Eli Lilly and Company